Ir al contenido
★ Inicia sesión para seguir
DS

Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Botanix Pharmaceuticals Ltd
Declaraciones totales
1
Empresa
1
▲ Compras (0 oper.)
—
▼ Ventas (0 oper.)
—

Última declaración publicada el 18 oct 2026 para Botanix Pharmaceuticals Ltd.

Historial del iniciado

Compras declaradas
0
Ventas declaradas
0
Historial de señales

No hay puntuaciones de señal disponibles.

Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust: resumen de sus operaciones

Una operación, una fecha: el 18 de octubre de 2026, Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust declaró una operación en Botanix Pharmaceuticals Ltd. Todavía no existe un historial más amplio. Fuente: declaraciones de directivos (ASX). Las operaciones pasadas no garantizan rentabilidades futuras.

Empresas y mercados vinculados a Daniel Sharp Date of last notice 24 April 2026 Date that director ceased to be director 17 October 2026 Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Consulte las fichas de empresa para ver las operaciones de insiders, los fundamentales y el consenso de analistas cuando esté disponible.

Declaraciones1 en total

1 de 1 declaración